SynthesisEndocrine2022

Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis.

Yonglang Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.